Skin involvement and pulmonary hypertension are associated with vitamin D insufficiency in scleroderma

International Journal of Molecular Sciences

Volumn 17, Issue 12, 2016, Pages

  Atteritano, Marco ^a   Santoro, Domenico ^a   Corallo, Giorgio ^a   Visalli, Elisa ^a   Buemi, Michele ^a   Catalano, Antonino ^a   Lasco, Antonino ^a   Bitto, Alessandra ^a   Squadrito, Francesco ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Immunomodulatory; Pulmonary hypertension; Skin; Systemic sclerosis; Vitamin D

Indexed keywords

ANTINUCLEAR ANTIBODY; CARBON MONOXIDE; CENTROMERE ANTIBODY; COLECALCIFEROL;

ACIDITY; ADULT; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD SAMPLING; CARBON DIOXIDE TENSION; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY SCORE; DISEASE DURATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GENDER; HEART RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION; LUNG ARTERY PRESSURE; LUNG CAPACITY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; OXYGEN SATURATION; PULMONARY HYPERTENSION; SKIN; SYSTEMIC SCLEROSIS; VITAMIN D DEFICIENCY; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; COMPLICATION; DEMOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY; PULMONARY ARTERY;

BLOOD PRESSURE; CASE-CONTROL STUDIES; CHOLECALCIFEROL; DEMOGRAPHY; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PULMONARY ARTERY; SCLERODERMA, SYSTEMIC; SKIN; VITAMIN D DEFICIENCY;

EID: 85006800076     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17122103     Document Type: Article

References (44)

1. Gabrielli, A.; Avvedimento, E.V.; Krieg, T. Scleroderma. N. Engl. J. Med. 2009, 360, 1989–2003.
2. Varga, J.; Abraham, D. Systemic sclerosis: A prototypic multisystem fibrotic disorder. J. Clin. Investig. 2007, 117, 557–567.
3. MacDonald, K.G.; Dawson, N.A.; Huang, Q.; Dunne, J.V.; Levings, M.K.; Broady, R. Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis. J. Allergy Clin. Immunol. 2015, 135, 946.
4. Veldman, C.M.; Cantorna, M.T.; Luca, H.F.D.E. Expression of 1,25-dihydroxyvitamin D3 receptor in the immune system. Arch. Biochem. Biophys. 2000, 374, 334–338.
5. Morgan, J.W.; Kouttab, N.; Ford, D.; Maizel, A.L. Vitamin D-mediated gene regulation in phenotypically defined B cells subpopulations. Endocrinology 2000, 141, 3225–3234.
6. Cutolo, M. Further emergent evidence for the vitamin D endocrine system involvement in autoimmune rheumatic disease risk and prognosis. Ann. Rheum. Dis. 2013, 72, 473–475.
7. Zerr, P.; Vollath, S.; Palumbo-Zerr, K.; Tomcik, M.; Huang, J.; Distler, A.; Beyer, C.; Dees, C.; Gela, K.; Distler, O. et al. Vitamin D receptor regulates TGF-β signalling in systemic sclerosis. Ann. Rheum. Dis. 2015, 74, e20.
8. Sadeghi, K.; Wessner, B.; Laggner, U.; Ploder, M.; Tamandl, D.; Friedl, J.; Zügel, U.; Steinmeyer, A.; Pollak, A.; Roth, E.; et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur. J. Immunol. 2006, 36, 361–370.
9. Delvin, E.; Souberbielle, J.C.; Viard, J.P.; Salle, B. Role of Vitamin D in acquired immune and autoimmune diseases. Crit. Rev. Clin. Lab. Sci. 2014, 51, 232–247.
10. Schneider, L.; Dos Santos, A.S.; Santos, M.; da Silva Chakr, R.M.; Monticielo, O.A. Vitamin D and systemic lupus erythematosus: State of the art. Clin. Rheumatol. 2014, 33, 1033–1038.
11. Costenbader, K.H.; Feskanich, D.; Holmes, M.; Karlson, E.W.; Benito-Garcia, E. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann. Rheum. Dis. 2008, 67, 530–535.
12. Rossini, M.; Gatti, D.; Viapiana, O.; Caimmi, C.; Idolazzi, L.; Fracassi, E.; Adami, S. Vitamin D and rheumatic diseases. Reumatismo 2014, 66, 153–170.
13. Merlino, L.A.; Curtis, J.; Mikuls, T.R.; Cerhan, J.R.; Criswell, L.A.; Saag, K.G.; Iowa Women’s Health Study. Vitamin D intake is inversely associated with rheumatoid arthritis: Results from the Iowa Women’s Health Study. Arthritis Rheum. 2004, 50, 72–77.
14. Cutolo, M.; Otsa, K.; Uprus, M.; Paolino, S.; Seriolo, B. Vitamin D in rheumatoid arthritis. Autoimmun. Rev. 2007, 7, 59–64.
15. Hollan, I.; Dessein, P.H.; Ronda, N.; Wasko, M.C.; Svenungsson, E.; Agewall, S.; Cohen-Tervaert, J.W.; Maki-Petaja, K.; Grundtvig, M.; Karpouzas, G.A.; et al. Prevention of cardiovascular disease in rheumatoid arthritis. Autoimmun. Rev. 2015, 14, 952–969.
16. Atteritano, M.; Sorbara, S.; Bagnato, G.; Miceli, G.; Sangari, D.; Morgante, S.; Visalli, E.; Bagnato, G. Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: A case control study. PLoS ONE 2013, 8, e66991.
17. Inoue, N.; Watanabe, M.; Ishido, N.; Katsumata, Y.; Kagawa, T.; Hidaka, Y.; Iwatani, Y. The functional polymorphisms of VDR, GC and CYP2R1 are involved in the pathogenesis of autoimmune thyroid diseases. Clin. Exp. Immunol. 2014, 178, 262–269.
18. D’Aurizio, F.; Villalta, D.; Metus, P.; Doretto, P.; Tozzoli, R. Is Vitamin D a player or not in the pathohystology of autoimmune thyroid diseases? Autoimmun. Rev. 2015, 14, 363–369.
19. Weinstock-Guttman, B.; Mehta, B.K.; Ramanathan, M.; Karmon, Y.; Henson, L.J.; Halper, J.; Riskind, P. Vitamin D and multiple sclerosis. Neurologist 2012, 18, 179–183.
20. Mutlu, A.; Mutlu, G.Y.; Özsu, E.; Çizmecioğlu, F.M.; Hatun, Ş. Vitamin D deficiency in children and adolescents with type 1 diabetes. J. Clin. Res. Pediatr. Endocrinol. 2011, 3, 179–183.
21. Lucisano, S.; Buemi, M.; Passantino, A.; Aloisi, C.; Cernaro, V.; Santoro, D. New insights on the role of vitamin D in the progression of renal damage. Kidney Blood Press Res. 2013, 37, 667–678.
22. Arnson, Y.; Amital, H.; Shoenfeld, Y. Vitamin D and autoimmunity: New aetiological and therapeutic considerations. Ann. Rheum. Dis. 2007, 66, 737–742.
23. Holick, M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357, 266–281.
24. Motrich, R.D.; van Etten, E.; Depovere, J.; Riera, C.M.; Rivero, V.E.; Mathieu, C. Impact of vitamin D receptor activity on experimental autoimmune prostatitis. J. Autoimmun. 2009, 32, 140–148.
25. Shimada, A.; Kanazawa, Y.; Motohashi, Y.; Yamada, S.; Maruyama, T.; Ikegami, H. Evidence for association between vitamin D receptor BsmI polymorphism and type 1 diabetes in Japanese. J. Autoimmun. 2008, 30, 207–211.
26. Ibn Yacoub, Y.; Amine, B.; Laatiris, A.; Wafki, F.; Znat, F.; Hajjaj-Hassouni, N. Bone density in Moroccan women with systemic scleroderma and its relationships with disease-related parameters and vitamin D status. Rheumatol. Int. 2012, 32, 3143–3148.
27. Rios Fernández, R.; Fernández Roldán, C.; Callejas Rubio, J.L.; Ortego Centeno, N. Vitamin D deficiency in a cohort of patients with systemic scleroderma from the south of Spain. J. Rheumatol. 2010, 37, 1355.
28. Caramaschi, P.; Gassa, A.D.; Ruzzenente, O.; Volpe, A.; Ravagnani, V.; Tinazzi, I.; Barausse, G.; Bambara, L.M.; Biasi, D. Very Low levels of vitamin D in systemic sclerosis patients. Clin. Rheumatol. 2010, 29, 1419–1425.
29. Carnevale, V.; Modoni, S.; Pileri, M.; di Giorgio, A.; Chiodini, I.; Minisola, S.; Vieth, R.; Scillitani, A. Longitudinal evaluation of vitamin D status in healthy subjects from southern Italy: Seasonal and gender differences. Osteoporos. Int. 2001, 12, 1026–1030.
30. Szodoray, P.; Nakken, B.; Gaal, J.; Jonsson, R.; Szegedi, A.; Zold, E.; Szegedi, G.; Brun, J.G.; Gesztelyi, R.; Zeher, M.; et al. The complex role of vitamin D in autoimmune diseases. Scand. J. Immunol. 2008, 68, 261–269.
31. Arnson, Y.; Amital, H.; Agmon-Levin, N.; Alon, D.; Sánchez-Castañón, M.; López-Hoyos, M. Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: A retrospective cohort study and review of the literature. Autoimmun. Rev. 2011, 10, 490–494.
32. Ulrich, S.; Hersberger, M.; Fischler, M.; Huber, L.C.; Senn, O.; Treder, U.; Speich, R.; Schmid, C. Bone mineral density and secondary hyperparathyroidism in pulmonary hypertension. Open Respir. Med. J. 2009, 3, 53–60.
33. Demir, M.; Uyan, U.; Keçeoçlu, S.; Demir, C. The Relationship between Vitamin D Deficiency and Pulmonary Hypertension. Prague Med. Rep. 2013, 114, 154–161.
34. Ben-Shoshan, M.; Amir, S.; Dang, D.T.; Dang, L.H.; Weisman, Y.; Mabjeesh, N.J. 1α,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells. Mol. Cancer Ther. 2007, 6, 1433–1439.
35. Tuder, R.M.; Chacon, M.; Alger, L.; Wang, J.; Taraseviciene-Stewart, L.; Kasahara, Y.; Cool, C.D.; Bishop, A.E.; Geraci, M.; Semenza, G.L.; et al. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: Evidence for a process of disordered angiogenesis. J. Pathol. 2001, 195, 367–374.
36. Terrier, B.; Derian, N.; Schoindre, Y.; Chaara, W.; Geri, G.; Zahr, N.; Mariampillai, K.; Rosenzwajg, M.; Carpentier, W.; Musset, L. et al. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res. Ther. 2012, 14, R221.
37. Ritterhouse, L.L.; Crowe, S.R.; Niewold, T.B.; Kamen, D.L.; Macwana, S.R.; Roberts, V.C.; Dedeke, A.B.; Harley, J.B.; Scofield, R.H.; Guthridge, J.M.; et al. Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 2011, 70, 1569–1574.
38. LeRoy, E.C.; Black, C.; Fleischmajer, R.; Jablonska, S.; Krieg, T.; Medsger, T.A. Jr.; Rowell, N.; Wollheim, F. Scleroderma (systemic sclerosis): Classification, subset and pathogenesis. J. Rheumatol. 1988, 15, 202–205.
39. Valentini, G.; Silman, A.J.; Veale, D. Assessment of disease activity. Clin. Exp. Rheumatol. 2003, 21 (Suppl. 29), S39–S41.
40. Valentini, G.; Della Rossa, A.; Bombardieri, S.; Bencivelli, W.; Silman, A.J.; D’Angelo, S.; Cerinic, M.M.; Belch, J.F.; Black, C.M.; Bruhlmann, P.; et al. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann. Rheum. Dis. 2001, 60, 592–598.
41. Valentini, G.; Bencivelli, W.; Bombardieri, S.; D’Angelo, S.; Della Rossa, A.; Silman, A.J.; Black, C.M.; Czirjak, L.; Nielsen, H.; Vlachoyiannopoulos, P.G. European multicentre study to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann. Rheum. Dis. 2003, 62, 901–903.
42. Valentini, G. The assessment of the patient with systemic sclerosis. Autoimmun. Rev. 2003, 2, 370–376.
43. Medsger, T.A., Jr.; Bombardieri, S.; Czirjak, L.; Scorza, R.; Della Rossa, A.; Bencivelli, W. Assessment of disease severity and prognosis. Clin. Exp. Rheumatol. 2003, 3, 42–46.
44. Hoeper, M.M.; Bogaard, H.J.; Condiffe, R.; Frantz, R.; Khanna, D.; Kurzyna, M.; Langleben, D.; Manes, A.; Satoh, T.; Torres, F. et al. Definitions and diagnosis of pulmonary hypertension. J. Am. Coll. Cardiol. 2013, 62, D4250.